Omnicell (OMCL) Asset Writedowns and Impairment (2010 - 2024)

Omnicell (OMCL) has 10 years of Asset Writedowns and Impairment data on file, last reported at -$5.4 million in Q4 2024.

• On a quarterly basis, Asset Writedowns and Impairment rose 30.86% year-over-year to -$5.4 million in Q4 2024; TTM through Dec 2025 was -$5.4 million, a 77142.86% decrease from a year earlier, with the FY2014 full-year figure at $350000.0, up 218.18% from the prior year.
• Asset Writedowns and Impairment for Q4 2024 stood at -$5.4 million, down from $5.4 million in the prior quarter.
• Over the last five years, Asset Writedowns and Impairment for OMCL reached as high as $7.8 million in Q1 2023 and fell as low as -$7.8 million in Q4 2023.
• Historically, Asset Writedowns and Impairment has averaged $1.6 million across 3 years, with a median of $2.5 million in 2022.
• On a YoY basis, Asset Writedowns and Impairment climbed as much as 2500.0% in 2023 and fell as far as 44.71% in 2023.
• Year by year, Asset Writedowns and Impairment stood at -$5.4 million in 2022, then sank by 44.71% to -$7.8 million in 2023, then surged by 30.86% to -$5.4 million in 2024.
• Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were -$5.4 million in Q4 2024, $5.4 million in Q2 2024, and -$7.8 million in Q4 2023.